The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 9, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 6
- −1 vs. Q3 2023
- Portfolio value
- $151.4M
- +$769.1K (+0.5%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RAPTRAPT Therapeutics, Inc. | COM | 2,680,621 | $66.6M | 44.0% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,568,181 | $32.8M | 21.7% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $30.5M | 20.1% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 18,136,735 | $15.6M | 10.3% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 627,651 | $5.90M | 3.9% | 00.0% | UnchangedConverted for a 1-for-15 split | History |
| RVMDRevolution Medicines, Inc. | COM | 46 | $1.32K | <0.1% | −1,230,595−100.0% | Reduced | History |
Sold out since Q3 2023 (1)
Positions held at the end of Q3 2023 that are gone from this filing.